Clinical trial
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and…
NCT00266279 · University of Louisville, Other · Completed
Key facts
| NCT number | NCT00266279 |
|---|---|
| Title | Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies |
| Official title | Phase II Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head or Neck Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Capecitabine |
| Enrollment | 17 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Dec 16, 2005 |
| Last update posted | Sep 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: